Liwen Chen
Guiyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation.
Journal: Journal of gastroenterology
Published: February 05, 2026
INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism.
Journal: Cancer cell international
Published: March 14, 2025
ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer.
Journal: Cell death & disease
Published: February 18, 2025
ANXA1 promotes intrahepatic cholangiocarcinoma proliferation and growth by regulating glutamine metabolism through GOT1 stabilization.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 11, 2025
TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: July 15, 2024
Senescence-related circRNA circHIF-1α is associated with pancreatic cancer progression.
Journal: Cancer cell international
Published: May 01, 2024
HOXC4 promotes proliferation of pancreatic cancer cells by increasing LDHA-mediated glycolysis.
Journal: Aging
Published: October 30, 2023
miR-660 promotes liver cancer cell proliferation by targeting PPP2R2A.
Journal: Experimental and therapeutic medicine
Published: October 14, 2018
MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 15, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026